@article{3021001,
    title = "Screening for and optimal management of small abdominal aortic aneurysms: The quest continues",
    author = "Paraskevas, K.I. and Eckstein, H.-H. and Nicolaides, A.N. and Geroulakos, G.",
    journal = "Current Vascular Pharmacology",
    year = "2020",
    volume = "18",
    number = "6",
    pages = "663-666",
    publisher = "Bentham Science Publishers",
    issn = "1570-1611",
    doi = "10.2174/1570161118999191126145824",
    keywords = "2,4 thiazolidinedione derivative;  advanced glycation end product;  antisense oligonucleotide;  antithrombocytic agent;  azithromycin;  corticosteroid;  gelatinase A;  gelatinase B;  hydroxymethylglutaryl coenzyme A reductase inhibitor;  lipoprotein A;  metformin;  plasmin;  roxithromycin, abdominal aortic aneurysm;  all cause mortality;  aneurysm rupture;  aneurysm size;  ankle brachial index;  atherosclerotic plaque;  atrial fibrillation;  carotid artery obstruction;  coronary artery disease;  cost effectiveness analysis;  diabetes mellitus;  Editorial;  endovascular aneurysm repair;  follow up;  high risk population;  human;  hyperlipidemia;  hypertension;  mortality;  patient selection;  prevalence;  randomized controlled trial (topic);  risk factor;  screening;  sex difference;  smoking;  transient ischemic attack;  abdominal aortic aneurysm;  aged;  clinical decision making;  diagnostic imaging;  disease exacerbation;  female;  male;  mass screening;  middle aged;  predictive value;  prognosis;  risk assessment, Aged;  Aortic Aneurysm, Abdominal;  Clinical Decision-Making;  Diagnostic Screening Programs;  Disease Progression;  Female;  Humans;  Male;  Mass Screening;  Middle Aged;  Predictive Value of Tests;  Prognosis;  Risk Assessment;  Risk Factors"
}